NuVasive® is an innovative medical device company focused on developing minimally disruptive surgical products and procedures for the spine. Its mission is to improve the lives of patients who suffer from debilitating back, neck or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery and achieve superior clinical results.
Through innovative technological advancements, NuVasive has successfully turned major spine surgery into the equivalent of outpatient surgery. Many patients are experiencing extraordinary results—they are often walking the same day of surgery, suffering less blood loss, spending less time in the hospital, and are back to work within four to six weeks (versus six months).
NuVasive offers more than 65 products spanning lumbar, thoracic, and cervical applications, as well as a portfolio of biologics. Its products have been used in hundreds of thousands of spine surgeries. NuVasive is the 4th largest spine company in the U.S., and the 5th largest globally.
NuVasive had revenue of $500 million in 2010 and employs more than 1,100 people. Corporate headquarters are in San Diego, California and additional offices are in Memphis, Tennessee and Paramus, New Jersey; as well as Puerto Rico, the United Kingdom, Germany, Australia, Singapore, and Japan.
For more information about NuVasive and minimally disruptive spine surgery, visit www.nuvasive.com.
The Society of Lateral Access Surgery (SOLAS®) was formed to advance the art and science of lateral access surgical techniques. This is accomplished via the establishment of forums for surgeon-to-surgeon communication, ongoing clinical education, and research. Through membership in the society, surgeons can undergo advanced training, conduct clinical studies, and publish scientific papers.
SOLAS, an organization developed and funded by NuVasive®, Inc., is made up of thought leaders and pioneering adopters of this innovative surgical approach. The outlook for the future of lateral access surgery is bright, and SOLAS is committed to developing and promoting new techniques that will benefit patients, physicians, and hospitals worldwide.
More information about lateral access surgery and the Society can be found on the SOLAS Web site (www.lateralaccess.org).